Literature DB >> 11495608

Statins and fracture risk.

C R Meier, R G Schlienger, M E Kraenzlin, B Schlegel, H Jick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11495608     DOI： 10.1001/jama.286.6.669

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  HMG CoA reductase inhibitors and the skeleton: a comprehensive review.

Authors:  D C Bauer
Journal:  Osteoporos Int       Date:  2003-05-08       Impact factor: 4.507

2.  Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.

Authors:  Lucia S Graham; Farhad Parhami; Yin Tintut; Christina M R Kitchen; Linda L Demer; Rita B Effros
Journal:  Clin Immunol       Date:  2009-08-22       Impact factor: 3.969

Review 3.  HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?

Authors:  Raymond G Schlienger; Christoph R Meier
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.

Authors:  Nusrat Shafiq; Samir Malhotra; Promila Pandhi; Anil Grover
Journal:  J Negat Results Biomed       Date:  2005-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.